Halogenated aryl hydrocarbon-induced suppression of the in vitro plaque-forming cell response to sheep red blood cells is not dependent on the Ah receptor-Reference-Cited by-同舟云学术

Halogenated aryl hydrocarbon-induced suppression of the in vitro plaque-forming cell response to sheep red blood cells is not dependent on the Ah receptor

Published:1991-05 Issue:3 Volume:21 Page:183-190
ISSN:0162-3109
Container-title:Immunopharmacology
language:en
Short-container-title:Immunopharmacology

Author:

Davis D.,Safe S.

Publisher

Elsevier BV

Subject

Pharmacology

Reference31 articles.

1. 6-Methyl-1,3,8-trichlorodibenzofuran (MCDF) as a 2,3,7,8-tetrachlorodibenzo-p-dioxin antagonist in C57BL/6 mice;Bannister;Toxicol,1989

2. The Ah regulatory gene product. Survey of nineteen polycyclic aromatic compounds and fifteen benzo[a]pyrene metabolites capacity to bind to the cytosolic receptor;Bigelow;Tox Letters,1982

3. α-Naphthoflavone antagonism of 2,3,7,8-TCDD induced murine lymphocyte ethoxyresorufin O-deethylase activity and immunosuppression;Blank;Mol Pharmacol,1987

4. Immunosuppressive activities of polychlorinated dibenzofuran congeners: Quantitative structure-activity relationships and interactive effects;Davis;Toxicol Appl Pharmacol,1988

5. Immunotoxicity of Halogenated Aromatic Hydrocarbons: QSAR and Interactive Effects;Davis,1989

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. immunological disorders associated with PCBs and related halogenated aromatic hydrocarbon compounds;CABI Compendium;2022-01-07

2. History of Research on the AHR;The AH Receptor in Biology and Toxicology;2011-11-10

3. Growth factors, cytokines and their receptors as downstream targets of arylhydrocarbon receptor (AhR) signaling pathways;Biochemical Pharmacology;2009-02

4. Chapter 15 New methods in immunotoxicology;Immunotoxicology of Drugs and Chemicals: an Experimental and Clinical Approach - Volume I: Principles and Methods of Immunotoxicology;2004

5. Recent advances in understanding the mechanisms of TCDD immunotoxicity;International Immunopharmacology;2002-02